Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Spectrum Pharma Inc (SPPI)

Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 211,403
  • Shares Outstanding, K 205,246
  • Annual Sales, $ 10,110 K
  • Annual Income, $ -75,400 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.14
  • Price/Sales 20.90
  • Price/Cash Flow N/A
  • Price/Book 7.89
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.02 on 05/09/23
  • Next Earnings Date 08/10/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.150 on 12/18/12
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.04
  • Number of Estimates 3
  • High Estimate -0.01
  • Low Estimate -0.07
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +76.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9269 +11.12%
on 07/11/23
1.0600 -2.83%
on 07/31/23
+0.0700 (+7.29%)
since 06/30/23
3-Month
0.9269 +11.12%
on 07/11/23
1.3600 -24.26%
on 05/11/23
+0.0550 (+5.64%)
since 04/28/23
52-Week
0.3150 +226.98%
on 12/27/22
1.5700 -34.39%
on 08/15/22
+0.2170 (+26.69%)
since 07/29/22

Most Recent Stories

More News
SPPI Deadline: Rosen Law Firm Urges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)...

SPPI : 1.0300 (unch)
SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025

PHILADELPHIA , Sept. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against  Spectrum...

SPPI : 1.0300 (unch)
ASRT : 0.7701 (+0.34%)
NASDAQ: SPPI CLASS ACTION NOTICE: Berger Montague Encourages Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action

PHILADELPHIA , Aug. 19, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against  Spectrum...

SPPI : 1.0300 (unch)
ASRT : 0.7701 (+0.34%)
Rosen Law Firm Urges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers and acquirers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) common stock between...

SPPI : 1.0300 (unch)
Spectrum Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPPI

The DJS Law Group reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. (“Spectrum” or “the Company”) (NASDAQ: SPPI ) for violations of §§10(b)...

SPPI : 1.0300 (unch)
Berger Montague PC Investigating Claims on Behalf of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors

PHILADELPHIA , Aug. 6, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against  Spectrum...

SPPI : 1.0300 (unch)
ASRT : 0.7701 (+0.34%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, ASRT, MDWT, SPPI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MDWT : 26.99 (unch)
SPPI : 1.0300 (unch)
FOCS : 52.99 (-0.02%)
ASRT : 0.7701 (+0.34%)
Are (More) Big Gains Ahead for This Small Cap Biotech Stock?

With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.

SPPI : 1.0300 (unch)
PTGX : 90.66 (+1.13%)
BMEA : 1.2900 (+5.74%)
Spectrum Pharma: Q1 Earnings Snapshot

Spectrum Pharma: Q1 Earnings Snapshot

SPPI : 1.0300 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, NATI, SPPI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CVT : 8.52 (+0.24%)
SPPI : 1.0300 (unch)
NATI : 59.98 (unch)

Business Summary

Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and...

See More

Key Turning Points

3rd Resistance Point 1.1579
2nd Resistance Point 1.1089
1st Resistance Point 1.0695
Last Price 1.0300
1st Support Level 0.9811
2nd Support Level 0.9321
3rd Support Level 0.8927

See More

52-Week High 1.5700
Fibonacci 61.8% 1.0906
Last Price 1.0300
Fibonacci 50% 0.9425
Fibonacci 38.2% 0.7944
52-Week Low 0.3150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar